Leadership

The Symetria Health® leadership team pioneered the breakthrough treatment methods and medications utilized to deliver the most successful outcomes.

Chris Hassan, Founder and Chief Executive Officer

Chris Hassan, Founder and Chief Executive Officer

Chris Hassan is a senior executive with over 25 years of experience in the field of healthcare and is the creator of the outpatient treatment model for opioid dependence therapy. Prior to founding Symetria Health®, Chris was the co-founder of Reckitt Benckiser Pharmaceuticals responsible for the commercialization and manufacture of the foundational modalities of medication assisted treatment: Suboxone® and Subutex®.

Previously in his career, Chris also served as the Chief Executive Officer of Colonial Management Group – one of the largest chain of opioid addiction treatment centers in the US. He has also developed and patented a number of new opioid product combinations focused on preventing diversion and inadvertent benzodiazepine overdose in opioid patients.

Chris is active on a number national panels and corporate boards while also serving as a Huffington Post contributor.

Tim Bohman, Chief Operating Officer

Tim Bohman, Chief Operating Officer

As Symetria Health®’s Chief Operating Officer, Tim Bohman is responsible for planning and implementing the company’s policies and objectives; executing growth strategies, including new program development; overseeing the efficiency and effectiveness of patient services; as well as managing the marketing and outreach efforts for the organization.

Tim has over 20 years of experience working with opioid treatment programs and clinics. His past experience includes Clinic Director for Lewin Clinics, Director of Development and Regional Director for National Specialty Clinics and, most recently, as Regional Vice President for Acadia Healthcare and CRC Health Group before it was acquired by Acadia. In his previous roles, Tim has fostered key relationships with regulators and legislators at both the state and national level, working with lobbyists to introduce legislative initiatives and defending best practices in addiction treatment. Tim is also the past president of INTOD, Indiana’s OTP provider association and was a former board member of AATOD.

Martyn Gibson, Chief Financial Officer

Martyn Gibson, Chief Financial Officer

As Symetria Health®’s Chief Financial Officer, Martyn Gibson is responsible for all aspects of finance and accounting, IS infrastructure, strategic planning and forecasting, revenue and cash flow management.

Martyn joined Symetria following 12 years with Reckitt Benckiser Pharmaceuticals supporting the commercialization and manufacturing of Suboxone®, Subutex® and Buprenex®. Martyn served as Global Head of Finance for the division, with responsibilities that included strategic planning, supply chain management and IS as part of the founding commercial leadership team. Martyn has consulted with several leading companies and brands within the substance use disorder treatment segment. He has Fellowship designation from the Association of Chartered Certified Accountants (ACCA) and has been an Honorary Board Member and Treasurer of a non-profit organization offering substance use disorder treatment services since 2008.

Dr. Abid K. Nazeer, M.D., Medical Director

Dr. Abid K. Nazeer, M.D., Medical Director

Dr. Abid Nazeer is board certified in Psychiatry and is a member of the American Society of Addiction Medicine. In this role at Symetria Health®, Dr. Nazeer is responsible for guiding The Symetria Method®®® protocol and providing psychiatric and addiction medicine care at Symetria Recovery® treatment centers. He is also responsible for the outpatient medication management of patients with a co-existing psychiatric illness or on medication for psychiatric diagnosis. Additionally, he works closely with Symetria Recovery®’s staff and patients to educate them on the potential impact that unresolved psychiatric symptoms, such as anxiety or depression, can have on the recovery process and he develops treatment plans for patients that have dual diagnosis.

Previously, Dr. Nazeer served as medical director for the Chemical Dependency IOP at Presence Mercy Medical Center (Aurora, IL) and Willis Knighton Addiction Recovery Center in Louisiana. He trained and held the role of Chief Resident at Louisiana State University Shreveport.

Results

99% of patients did not require admission to a higher level of care than we offer onsite.

The proof is in the numbers

Results

80% of patients participated in preventive health screenings and immunizations.

The proof is in the numbers

Results

92% of patients were able to avoid unplanned hospitalization.

The proof is in the numbers

Results

80% of patients were able to reduce or abstain from tobacco use.

The proof is in the numbers

Results

96% of patients were able to reduce or abstain from alcohol use.

The proof is in the numbers